300
Participants
Start Date
October 17, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
4-MUST
128 mg of trimebutine 4-methylumbelliferyl sulfate tablet.
Placebo
Placebo tablet.
RECRUITING
"Limited Liability Company Medical Center Eco-Safety", Saint Petersburg
RECRUITING
"State Budgetary Institution of Healthcare of Moscow City Polyclinic No. 2 of the Moscow Department of Healthcare", Moscow
RECRUITING
Unimed-C Jsc, Moscow
RECRUITING
Ivanovo Kuvaev Clinical Hospital, Ivanovo
RECRUITING
"Limited Liability Company Energy of Health", Saint Petersburg
RECRUITING
"St. Petersburg State Budgetary Healthcare Institution City Polyclinic No. 117", Saint Petersburg
RECRUITING
"Limited Liability Company Clinic Zvezdnaya", Saint Petersburg
RECRUITING
"Limited Liability Company Meili", Saint Petersburg
RECRUITING
"State autonomous health care institution Engels City Clinical Hospital No. 1", Engel's
RECRUITING
Professors' Clinic LLC., Perm
RECRUITING
"The State Budgetary Healthcare Institution of the Moscow Region Moscow Regional Research Clinical Institute named after M.F. Vladimirsky", Moscow
RECRUITING
"Limited Liability Company ErSi Medical", Novosibirsk
RECRUITING
"State Budgetary Institution St. Petersburg Research Institute of Emergency Care named after I.I. Djanelidze", Saint Petersburg
RECRUITING
"Private institution of higher education Medical University 'Reavis'", Samara
RECRUITING
"Association Regional Medical Center 'Open Medicine'", Tolyatti
RECRUITING
"LLC Polyclinic Polimedika Veliky Novgorod", Veliky Novgorod
RECRUITING
"Limited Liability Company Medical Center for Diagnosis and Prevention Plus", Yaroslavl
Valenta Pharm JSC
INDUSTRY